HCAT
Undervalued by 76.6% based on the discounted cash flow analysis.
Market cap | $327.95 Million |
---|---|
Enterprise Value | $259.29 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-2.09 |
Beta | 0.0 |
Outstanding Shares | 58,563,005 |
Avg 30 Day Volume | 610,210 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -2.78 |
---|---|
PEG | 18.16 |
Price to Sales | 1.21 |
Price to Book Ratio | 1.01 |
Enterprise Value to Revenue | 0.88 |
Enterprise Value to EBIT | -2.04 |
Enterprise Value to Net Income | -3 |
Total Debt to Enterprise | 0.96 |
Debt to Equity | 0.68 |
No data
No data